Personalized Medicine and Bladder Cancer with Dr. Milowsky

June 17, 2021

In Episode 8 of “Bladder Cancer Matters,” host Rick Bangs interviews Dr. Matthew Milowsky about genetics, genomics and personalized medicine for bladder cancer treatment. Dr. Milowsky is the Section Chief, Genitourinary Oncology; Co-Director, Urologic Oncology Program University of North Carolina School of Medicine. Dr. Milowsky is also the chair of the Bladder Cancer Genomics Consortium. In this episode, Rick and Dr. Kamat discuss:

What the Bladder Cancer Genomics Consortium is and what it does
What an “exceptional responder” is is bladder cancer
The importance of clinical studies to the future of bladder cancer
How philanthropy propels bladder cancer medical research

Never miss an episode of “Bladder Cancer Matters” by subscribing on your favorite podcast platform.

Personalized Medicine and Bladder Cancer with Dr. Matthew Milowsky

Read Our Stories

Read Brian’s Story

Read Colleen’s Story: “It is important to take each day as it comes because the obstacles seem insurmountable in the beginning.”

Read Ronald’s Story: “Trust your gut.”

Read Anita’s Story: “We have to be our own advocates and live life as bravely and as fully as we can.”